The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Phase 2 trial of durvalumab and radiation revaccination in patients with metastatic adenocarcinoma of the pancreas who have progressed through first-line chemotherapy.

Michael David  Chuong

Honoraria - Quantia MD

Speakers' Bureau - Accuray; ViewRay

Research Funding - AstraZeneca

Travel, Accommodations, Expenses - Accuray

Shahed Nicolas  Badiyan

No Relationships to Disclose

Minesh P.  Mehta

Leadership - Oncoceutics

Stock and Other Ownership Interests  - Pharmacyclics

Consulting or Advisory Role - Abbvie; Agenus; AstraZeneca; Celgene; IBA; Insys Therapeutics; Oncoceutics; Remedy Pharmaceuticals; Tocagen; Varian Medical Systems

Patents, Royalties, Other Intellectual Property - WARF patent 14/934,27, TOPICAL VASOCONSTRITOR PREPARATIONS AND METHODS FOR PROTECTING CELLS DURING CANCER CHEMOTHERAPY AND RADIOTHERAPY

Other Relationship - Monteris Medical